Header Logo

Connection

Douglas Corley to Cyclin-Dependent Kinase Inhibitor p16

This is a "connection" page, showing publications Douglas Corley has written about Cyclin-Dependent Kinase Inhibitor p16.
  1. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014 Dec; 35(12):2740-7.
    View in: PubMed
    Score: 0.126

© 2024 Kaiser Permanente